Your browser doesn't support javascript.
loading
Discovery and Protein Modeling Studies of Novel Compound Mutations Causing Resistance to Multiple Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia.
Iqbal, Zafar; Absar, Muhammad; Mahmood, Amer; Aleem, Aamer; Iqbal, Mudassar; Jameel, Abid; Akhtar, Tanveer; Karim, Sajjad; Rasool, Mahmood; Mirza, Zeenat; Khalid, Muhammad; Akram, Afia Muhammad; Sabar, Muhammad Farooq; Khalid, Ahmad M; Aljarrah, Khalid; Iqbal, Janhangir; Khalid, Muhammad; Shah, Ijaz H; Alanazi, Nawaf.
Afiliação
  • Iqbal Z; Hematology Oncology and Pharmacogenetics Engineering Sciences (HOPES) Group, Health Sciences Research Laboratories, Department of Zoology, University of the Punjab, Lahore, & University of Education, Lahore, Pakistan.
  • Absar M; Hematology Oncology and Pharmacogenetics Engineering Sciences (HOPES) Group, Health Sciences Research Laboratories, Department of Zoology, University of the Punjab, Lahore, & University of Education, Lahore, Pakistan.
  • Mahmood A; Department of Anatomy, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.
  • Aleem A; Hematology/Oncology Division, Department of Medicine, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.
  • Iqbal M; Foreign Faculty, Asian Medical Institute, Kant City, National Surgical Centre, Bishkek, Kyrgyzstan, and Higher Education Commission Program in "Hematology Oncology and Pharmacogenetics Engineering Sciences (HOPES)", Kyrgyzstan.
  • Jameel A; Post-Graduate Medical Institute, Hayatabad Medical Complex, Peshawar, Pakistan.
  • Akhtar T; Hematology Oncology and Pharmacogenetics Engineering Sciences (HOPES) Group, Health Sciences Research Laboratories, Department of Zoology, University of the Punjab, Lahore, & University of Education, Lahore, Pakistan.
  • Karim S; Center of Excellence in Genomic Medicine Research & Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Rasool M; Center of Excellence in Genomic Medicine Research & Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Mirza Z; Center of Excellence in Genomic Medicine Research & Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Khalid M; Blood Bank, Peshawar, Pakistan.
  • Akram AM; Department of Zoology, Division of Science and Technology, University of Education, Township, Lahore, Pakistan.
  • Sabar MF; Centre for Advanced Molecular Biology, University of the Punjab, Lahore, Pakistan.
  • Khalid AM; Departments of Biotechnology and Genomic Medicine, University of Sialkot, Pakistan.
  • Aljarrah K; College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS)/ KAIMRC/SSBMT, National Guards Health Affairs, Al-Ahsa, Kingdom of Saudi Arabia.
  • Iqbal J; Jordan University of Science and Technology, Irbid, Jordan.
  • Khalid M; National Guard Health Affairs, King Abdullah International Medical Research Centre (KAIMRC), Al-Ahsa, Saudi Arabia.
  • Shah IH; Allied Hospital, Punjab Medical College & Sahil Hospital, Faisalabad, Pakistan.
  • Alanazi N; Allied Hospital, Punjab Medical College & Sahil Hospital, Faisalabad, Pakistan.
Asian Pac J Cancer Prev ; 21(12): 3517-3526, 2020 12 01.
Article em En | MEDLINE | ID: mdl-33369447
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Biomarcadores Tumorais / Proteínas de Fusão bcr-abl / Resistencia a Medicamentos Antineoplásicos / Mesilato de Imatinib / Mutação Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Asian Pac J Cancer Prev Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Paquistão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Biomarcadores Tumorais / Proteínas de Fusão bcr-abl / Resistencia a Medicamentos Antineoplásicos / Mesilato de Imatinib / Mutação Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Asian Pac J Cancer Prev Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Paquistão